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Tau antagonizes end-binding protein tracking 
at microtubule ends through a phosphorylation-
dependent mechanism
ABSTRACT Proper regulation of microtubule dynamics is essential for cell functions and in-
volves various microtubule-associated proteins (MAPs). Among them, end-binding proteins 
(EBs) accumulate at microtubule plus ends, whereas structural MAPs bind along the microtu-
bule lattice. Recent data indicate that the structural MAP tau modulates EB subcellular local-
ization in neurons. However, the molecular determinants of EB/tau interaction remain un-
known, as is the effect of this interplay on microtubule dynamics. Here we investigate the 
mechanisms governing EB/tau interaction in cell-free systems and cellular models. We find 
that tau inhibits EB tracking at microtubule ends. Tau and EBs form a complex via the C-ter-
minal region of EBs and the microtubule-binding sites of tau. These two domains are required 
for the inhibitory activity of tau on EB localization to microtubule ends. Moreover, the phos-
phomimetic mutation S262E within tau microtubule-binding sites impairs EB/tau interaction 
and prevents the inhibitory effect of tau on EB comets. We further show that microtubule 
dynamic parameters vary, depending on the combined activities of EBs and tau proteins. 
Overall our results demonstrate that tau directly antagonizes EB function through a phos-
phorylation-dependent mechanism. This study highlights a novel role for tau in EB regulation, 
which might be impaired in neurodegenerative disorders.
INTRODUCTION
Microtubules are major components of the eukaryotic cytoskeleton 
and are essential for intracellular transport, mitosis, and cellular ar-
chitecture (Desai and Mitchison, 1997). They are 25-nm hollow cyl-
inders resulting from the assembly of α/β-tubulin heterodimers 
(Amos and Schlieper, 2005). Microtubule ends constantly oscillate 
between phases of polymerization and depolymerization, a behav-
ior known as dynamic instability (Mitchison and Kirschner, 1984). 
Transitions from growth to shortening are referred to as catastro-
phes and reverse events as rescues. In living cells, a variety of micro-
tubule-associated proteins (MAPs) interact with free tubulin and/or 
microtubules to regulate their properties and spatial organization. 
Plus end– tracking proteins (+TIPs) are a diverse group of MAPs that 
preferentially associate with the growing plus ends of microtubules 
(Galjart, 2010). The +TIPs form a complex interaction network at 
microtubule plus ends, where they control both microtubule dynam-
ics and microtubule anchorage to distinct subcellular targets (e.g., 
cell cortex, vesicles, kinetochores).
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Among the +TIP family, end-binding protein 1 (EB1) is consid-
ered as a major integrator of microtubule end behavior (Akhmanova 
and Steinmetz, 2010). EB1 autonomously end-tracks growing micro-
tubules, where it recruits many other +TIPs, ensuring tight control of 
microtubule properties (Bieling et al., 2007; Dixit et al., 2009; 
Honnappa et al., 2009; Zanic et al., 2009; Zimniak et al., 2009). EB1 
and its homologues (EB2 and 3) in mammals are composed of an 
N-terminal calponin-homology domain, which is required for micro-
tubule binding, and a C-terminal dimerization domain (Hayashi and 
Ikura, 2003; Honnappa et al., 2005; Slep et al., 2005; De Groot 
et al., 2010). The C-terminal part includes a unique EB1 homology 
(EBH) domain followed by an acidic C-terminal tail, both of which 
are involved in the interactions of EBs with multiple partners 
(Akhmanova and Steinmetz, 2010). Because of its central role in the 
+TIP network, the association of EB1 with microtubule ends is tightly 
regulated to ensure precise spatiotemporal control of the cytoskel-
eton. The mechanisms underlying this regulation, however, are 
poorly understood.
Recent studies have proposed that the localization of EB proteins 
(EB1 and 3) on microtubules is modulated by structural MAPs pri-
marily characterized by their binding along the microtubule lattice 
(Kapitein et al., 2011; Sayas and Avila, 2014; Velot et al., 2015). Ex-
amples of this cross-talk include MAP2-dependent distribution of 
EB3 along dendritic microtubules upon neuronal activation (Kapitein 
et al., 2011) and sequestration of EB1/3 by MAP1B in the cytosol of 
neuronal cells (Tortosa et al., 2013). Tau is another major structural 
MAP involved in the neuronal development and maintenance of the 
brain integrity. We recently identified tau as a partner of EBs in neu-
rons and found that tau regulates EB subcellular localization (Sayas 
et al., 2015). The molecular basis of such interplay and the conse-
quences for microtubule dynamic behavior are unknown.
Here we sought to dissect how tau and its phosphorylation af-
fect EB behavior at microtubule tips. We provide biochemical and 
cell-biological evidence that tau inhibits the microtubule-end track-
ing properties of EBs. We find that the basic microtubule-binding 
sites of tau directly interact with the C-terminal region of EBs and 
that these two interacting domains are required for the inhibitory 
activity of tau on EB localization to microtubule ends. Of note, a 
phosphomimetic mutation S262E within tau microtubule-binding 
sites impairs EB/tau interaction. This S262E-tau mutant does not 
inhibit the formation of EB comets. Our results further show that the 
parameters of microtubule dynamics change depending on the 
combined activities of EB and tau proteins. Taken together, our data 
support a novel mechanism by which tau directly regulates EB prop-
erties at microtubule ends.
RESULTS
Tau inhibits EB1 tracking at microtubule plus ends
We investigated whether tau affected EB1 intrinsic properties by 
reconstituting in vitro microtubule dynamics and EB1 tracking at mi-
crotubule ends using total internal reflection fluorescence (TIRF) mi-
croscopy (Figure 1A). Red-labeled purified tubulin was nucleated 
from brightly fluorescent seeds, and microtubule behavior was ana-
lyzed in the presence of green fluorescent protein (GFP)–EB1, tau, 
and combinations of the two proteins. In the control conditions 
(tubulin alone), microtubules alternated between phases of growth 
and shortening (Table 1). GFP-EB1 formed comets at the extremity 
FIGURE 1: Tau inhibits EB1 tracking at microtubule ends in a 
concentration-dependent manner. (A) Kymographs of microtubules 
assembled in the presence of 75 nM GFP-EB1 alone or with 
combinations of 75 nM GFP-EB1 and increasing concentrations of tau 
(15, 35, and 75 nM). The white stars indicate rescues after catastrophe 
events. Horizontal and vertical bars, 5 μm and 60 s, respectively. MT, 
microtubule. (B) Histogram indicating GFP-EB1 fluorescence intensity 
at microtubule tips in the absence or presence of increasing tau 
concentration. **p < 0.01, ****p < 0.0001 (Kruskal–Wallis analysis of 
variance [ANOVA] followed by post hoc Dunn’s comparison; n = 35, 
75, 81, and 34 for GFP-EB1, GFP-EB1 + 15 nM tau, GFP-EB1 + 35 nM 
tau, and GFP-EB1 + 75 nM tau, respectively). The p values were 
calculated in comparison to the condition without tau. a.u., arbitrary 
units. (C) Catastrophe frequency vs. tau concentration in the absence 
(black) or presence (gray) of GFP-EB1. Data were fitted by a one-
phase exponential decay model (R2 = 0.99 for both data sets), and the 
two curves were significantly different with p = 0.02 (F-test). 
(D) Microtubule shrinkage rates measured with or without GFP-EB1 
(75 nM) and at increasing tau concentrations (0, 15, 35, and 75 nM). 
***p < 0.001 (Mann–Whitney U test, n = 22 and 104 for tau 15 nM and 
tau 15 nM + GFP-EB1, respectively). (E) Histograms showing GFP-EB1 
(left) and GFP-EB1-Δ-tail (right) fluorescence intensity at microtubule 
tips and on the microtubule lattice in the presence or absence of 
tau. Equimolar concentrations (75 nM) of GFP-EB1, GFP-EB1-Δ-tail, 
and tau were used. *p < 0.05, ****p < 0.0001 (Mann–Whitney U test 
comparison, n = 20 for each condition). All error bars represent SDs.
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GFP-EB1 strongly altered the capacity of tau to reduce the catastro-
phe rate compared with 15 nM tau alone. At this low tau:EB1 ratio, 
microtubules also disassembled faster than with tau alone, indicat-
ing that they were less stabilized (Figure 1D). These results sug-
gested that a fraction of tau might be prevented from binding to the 
microtubule wall in the presence of EB1. Moreover, cosedimenta-
tion assays revealed that an excess of EB1 could displace tau mol-
ecules bound to Taxol-stabilized microtubules (Supplemental Figure 
S1A and Supplemental Materials and Methods). In these conditions, 
a portion of EB1 associates with microtubules (Maurer et al., 2012; 
Zhang et al., 2015) and can compete with the microtubule-binding 
sites of tau. We thus produced a mutant of EB1 (EB1-KQ/EE) with 
impaired microtubule-binding properties by substituting K100 and 
Q102 in the CH domain with glutamate residues (Maurer et al., 
2012; Zhang et al., 2015). EB1-KQ/EE still induced a significant re-
lease of tau from microtubules (Supplemental Figure S1B), support-
ing the hypothesis that soluble EB1 affects tau binding to the micro-
tubule wall.
We then asked whether tau could recruit EB1 along the micro-
tubule wall in our reconstitution assay, since EB proteins have been 
identified as partners of structural MAPs in neurons (Kapitein et al., 
2011; Tortosa et al., 2013; Sayas et al., 2015; see later description). 
The very weak GFP-EB1 labeling observed along the microtubule 
lattice by TIRF microscopy was not enhanced in the presence of 
equimolar amount of tau (75 nM) and was even slightly reduced 
compared with GFP-EB1 alone (Figure 1E, left). To confirm this 
result, we produced a GFP-EB1 construct lacking the last 20 resi-
dues (GFP-EB1-Δ-tail) and exhibiting enhanced binding to the mi-
crotubule wall compared with full-length EB1 (Buey et al., 2011). 
The results showed that the intensity of GFP-EB1-Δ-tail decreased 
drastically both at microtubule ends and along the microtubule 
lattice in the presence of equimolar amount of tau (Figure 1E, 
right). Thus tau inhibits the binding of EB1 along the microtubule 
wall in vitro.
of growing microtubules (Figure 1, A and B) and stimulated catastro-
phes (Table 1 and Supplemental Movie S1), as reported previously 
(Bieling et al., 2007; Vitre et al., 2008; Komarova et al., 2009; Zanic 
et al., 2013). Conversely, tau strongly decreased the catastrophe fre-
quency (from 0.149 event/min in the tubulin-alone control to 0.005 
event/min with the highest tau concentration; Table 1), induced res-
cues, and slowed the microtubule shrinkage rate (Table 1). Such ef-
fects already could be observed at very low tau:tubulin ratios (15 nM 
tau; Table 1) and are consistent with the known microtubule-stabiliz-
ing properties of this neuronal MAP (Panda et al., 1995, 2003). Strik-
ingly, the simultaneous addition of GFP-EB1 and tau reduced GFP-
EB1 localization at microtubule ends in a tau concentration–dependent 
manner (Figure 1, A and B). Using a fixed amount of GFP-EB1 
(75 nM) and increasing concentrations of tau (0, 15, 35, and 75 nM), 
we observed a gradual decrease in GFP-EB1 comet intensity from 
100 a.u. in the absence of tau to 19 a.u with 75 nM tau (Figure 1B 
and Supplemental Movie S1). This progressive inhibition of GFP-
EB1 end-tracking properties was accompanied by large changes in 
microtubule dynamics. In the presence of GFP-EB1 alone, micro-
tubules were highly unstable, undergoing catastrophes without res-
cue events (i.e., total depolymerization of the polymer down to the 
seeds; Figure 1A and Table 1). On addition of 15 nM tau, a portion 
of the shrinking events was rescued before the total depolymeriza-
tion of microtubules due to concomitant destabilizing and stabiliz-
ing activities of EB1 and tau, respectively. In contrast, microtubules 
assembled with equimolar amounts (75 nM) of GFP-EB1 and tau 
grew persistently with a catastrophe frequency as low as with tau 
alone, showing that EB1 effects on microtubule dynamics were 
hampered by tau in this condition.
We next wondered whether EB1 could reciprocally affect the 
microtubule-regulating properties of tau. We noticed that, at sub-
stoichiometric tau concentrations relative to GFP-EB1, the inhibitory 
activity of tau on catastrophes was affected by the presence of GFP-
EB1 (Figure 1C). In particular, combination of 15 nM tau and 75 nM 
Growth rate  
(μm/min)
Shortening rate 
(μm/min)
Catastrophe frequency 
(events/min)
Rescue frequency 
(events/min)
Control 1.53 ± 0.25 31.78 ± 4.73 0.149 ± 0.014 0
n = 119 n = 102 n = 103
GFP-EB1 (75 nM) 1.91 ± 0.33 32.66 ± 5.62 0.232 ± 0.031 0
n = 59 n = 56 n = 56
tau (15 nM) 1.75 ± 0.28 21.09 ± 4.36 0.039 ± 0.008 1.66 ± 0.35
n = 54 n = 22 n = 20 n = 22
tau (35 nM) 1.70 ± 0.27 20.92 ± 4.99 0.018 ± 0.005 1.21 ± 0.38
n = 45 n = 12 n = 12 n = 10
tau (75 nM) 2.06 ± 0.27 19.32 ± 5.52 0.005 ± 0.0025 1.58 ± 0.79
n = 51 n = 4 n = 4 n = 4
GFP-EB1 + 15 nM tau 1.88 ± 0.35 26.01 ± 6.09 0.153 ± 0.015 1.75 ± 0.20
n = 125 n = 104 n = 97 n = 73
GFP-EB1 + 35 nM tau 1.76 ± 0.34 22.18 ± 4.35 0.064 ± 0.010 2.61 ± 0.43
n = 64 n = 37 n = 37 n = 36
GFP-EB1 + 75 nM tau 1.93 ± 0.23 18.73 ± 3.59 0.004 ± 0.002 1.36 ± 0.68
n = 42 n = 4 n = 4 n = 4
Dynamic parameters were measured for microtubules assembled with tubulin (12 μM) in the absence or presence of the indicated proteins. The total times of 
measurements (growing and shrinkage phases) were 723.80, 261.92, 514.74, 666.96, 742.74, 674.38, 583.67, and 850.78 min for tubulin alone, 75 nM GFP-EB1, 
15 nM tau, 35 nM tau, 75 nM tau, 75 nM GFP-EB1 + 15 nM tau, 75 nM GFP-EB1 + 35 nM tau, and 75 nM GFP-EB1 + 75 nM tau, respectively. n, number of events 
measured for each condition. Values represent mean ± SD.
TABLE 1: Effects of EB1 and tau on microtubule dynamics.
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N-terminal domain responsible for microtu-
bule binding and a C-terminal part involved 
in dimerization and interaction with many 
partners. We used the EB1-NL-LZ con-
struct, in which the whole C-terminal part of 
EB1 was removed and replaced by the leu-
cine zipper domain of yeast GCN4 to artifi-
cially dimerize the N-terminal domain of 
EB1 (Komarova et al., 2009; Buey et al., 
2011). Pull-down experiments revealed 
that EB1-NL-LZ was far less efficient in 
binding tau than EB1 (Figure 3A), indicat-
ing that EB1 interacted with tau through its 
C-terminal domain. We then evaluated by 
TIRF microscopy whether the C-terminal 
part of EBs was also required for the inhibi-
tory activity of tau on EB tracking at micro-
tubule tips. For these experiments, EB3 ap-
peared more suitable than EB1 since, in 
contrast with EB1, the removal of the C-
terminal part of EB3 does not significantly 
affect its microtubule end–binding proper-
ties (Komarova et al., 2009; Skube et al., 
2010; Buey et al., 2011). We thus used the 
chimera GFP-EB3-NL-LZ, which accumu-
lated at microtubule ends and promoted 
catastrophe events similar to GFP-EB3 
(Figure 3B and Table 2; Komarova et al., 
2009; Buey et al., 2011). Increasing concen-
trations of tau strongly decreased the 
comet intensity of GFP-EB3 (Figure 3, B 
and C, and Supplemental Movie S2), as ob-
served earlier for GFP-EB1 (Figure 1). 
Moreover, microtubules assembled with both GFP-EB3 and tau 
elongated with few catastrophes and some rescue events, showing 
that tau impeded the microtubule-destabilizing activity of EB3 
(Table 2). By contrast, for equimolar concentrations of tau and 
GFP-EB3-NL-LZ, tau did not inhibit GFP-EB3-NL-LZ binding at mi-
crotubule ends (comet intensity of 109 a.u. with 10 nM tau versus 
100 a.u. without tau), and we observed only a slight decrease of 
GFP-EB3-NL-LZ comet intensity at higher tau concentration (comet 
intensity of 68 a.u. with 40 nM tau compared with 100 a.u. without 
tau; Figure 3, B and D, and Supplemental Movie S3). In these condi-
tions, microtubules were highly dynamic and exhibited both catas-
trophes and rescues due to the concomitant microtubule-regulating 
activities of GFP-EB3-NL-LZ and tau, respectively (Table 2). Taken 
together, these results reveal that the C-terminal region of EBs inter-
acts with tau and is a key element for the inhibitory effect of tau on 
EB tracking at microtubule ends.
The basic microtubule-binding sites of tau directly interact 
with EB1
We next intended to determine the motifs of tau involved in EB1 
binding. Tau can be divided into two main regions (Figure 4A): an 
acidic, N-terminal projection domain and a basic, C-terminal do-
main, which is composed of a proline-rich region (P2), four con-
served basic repeats (R1–R4), and a C-terminal extension including a 
pseudorepeat (R′). The repeat motifs and flanking sequences (i.e., 
P2 and R′) constitute the microtubule-binding domain (MTBD) and 
are responsible for the microtubule-stabilizing properties of tau 
(Trinczek et al., 1995; Mukrasch et al., 2007, 2009). The N-terminal 
part of tau contains one putative consensus EB binding site (TXIP; 
We next investigated whether tau affected EB behavior in a cel-
lular model. Mouse embryonic fibroblasts, devoid of endogenous 
tau, were transfected with EGFP-tau and immunolabeled for EB1. In 
agreement with the results obtained with purified proteins, we ob-
served a reduction of EB1 comets in cells expressing tau (Figure 2, 
A and B). Quantifications showed that both the density (Figure 2C) 
and mean intensity (Figure 2D) of comets were markedly decreased. 
Furthermore, the mean length of comets was reduced from 2.28 μm 
± 0.06 (SEM, n = 70 comets) in nontransfected cells to 1.30 μm ± 
0.03 (n = 95 comets) in tau-transfected cells. We also noticed reloca-
tion of EB1 along tau-induced microtubule bundles in some cells 
expressing high levels of tau (Supplemental Figure S2; see Discus-
sion), as reported previously in neurons (Sayas et al., 2015). Overall 
these results demonstrate that tau inhibits EB1 localization at micro-
tubule ends.
Tau inhibitory effect on EB tracking at microtubule ends 
is mediated by the C-terminal part of EBs
The inhibitory effect of tau on EB1 end-tracking properties might 
rely on a direct interaction between tau and EB1. Accordingly, we 
recently identified tau as a partner of EB1 in neurons (Sayas et al., 
2015) and showed that EB1 directly binds tau in pull-down experi-
ments using purified proteins (Figure 3A and Supplemental Figure 
S3A). To quantify this interaction, we estimated the apparent affinity 
of tau and EB1 by fluorescence spectroscopy (Supplemental Figure 
S3B). EB1 fluorescence upon tau addition showed saturable quench-
ing, indicating the formation of a complex between the two proteins 
with an apparent dissociation constant of 1.7 ± 1.1 μM. We next 
determined the tau-interacting region in EB1. EBs consist of an 
FIGURE 2: Tau inhibits EB localization at microtubule ends in fibroblasts. (A) Mouse embryonic 
fibroblasts were transfected with pEGFP-tau and stained for EGFP (tau, gray), EB1 (red), and 
tubulin (MT, green). Right, merged image with EB1 and tubulin staining. Images include 
transfected and nontransfected cells in the same field. Bar, 10 μm. (B) Higher magnifications 
of nontransfected (−tau) and transfected (+tau) cells. Arrowheads point to comets. Bar, 10 μm. 
(C) EB1 comet density normalized to the microtubule network surface (comet number/100 μm2 
of microtubule network) in lamellipodia of nontransfected (−tau) or pEGFP-tau transfected 
(+tau) cells. The histogram shows the mean ± SEM. ****p < 0.0001, Mann-Whitney U test 
comparison (n = 80 and 88 regions of interest for –tau and +tau conditions, respectively). (D) The 
fluorescence intensity of comets was quantified in nontransfected (−tau) and transfected (+tau) 
cells and plotted against the distance from microtubule plus ends. Nonlinear regression curves 
fitting the mean fluorescence intensities ± SEM (70 and 95 comets for –tau and +tau conditions, 
respectively). a.u., arbitrary units.
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Supplemental Figure S4A; Honnappa et al., 2009). We performed 
several mutations to invalidate this site in the tau protein, but these 
mutations neither altered tau/EB1 interaction nor modified tau-de-
pendent inhibition of EB1 comets (Supplemental Figure S4, B and 
C). We thus focused on the basic domains of tau, as they might in-
teract with the negatively charged C-terminal part of EBs. We pro-
duced various forms of tau (Figure 4A): 0R-tau (deletion of the four 
repeats), R1R′-tau (tau fragment from R1 to R′), and P2R′-tau (tau 
fragment from P2 to R′). Removal of R1–R4 repeats (0R-tau) com-
pletely abolished tau interaction with EB1 (Figure 4B). EB1 still 
bound the two fragments R1R′- and P2R′-tau, however, indicating 
that the repeat motifs of tau are necessary for the formation of a 
complex between the two proteins. TIRF assays revealed that 0R-tau 
was not able to inhibit the tracking of GFP-EB1 at microtubule ends 
(Figure 4, C and D). This suggested that tau repeats were required 
for the inhibition of EB1 accumulation at microtubule ends. How-
ever, the minimal fragment R1R′-tau including the repeats only 
slightly decreased the comet intensity of GFP-EB1 compared with 
the full-length tau (68 vs. 8 a.u., respectively; Figure 4D). By contrast, 
the fragment of tau containing the P2 domain in addition to the re-
peat motifs (P2R′-tau fragment) strongly inhibited GFP-EB1 tracking 
at microtubule tips to the same extent as tau (7 and 8 a.u., respec-
tively; Figure 4D). Overall these data indicate that the inhibitory ac-
tivity of tau on EB comets requires both the microtubule-binding 
repeats and the P2 region of tau.
The interaction between tau and EB1 is regulated 
by phosphorylation
The microtubule-stabilizing properties of tau are tightly regulated 
by phosphorylation (Buee et al., 2000). Given that EB1 interacts with 
the basic microtubule-binding sites of the neuronal MAP, phosphor-
ylation in this region might affect tau/EB1 association. To address 
this question, we produced a phosphomimetic version of tau with 
the serine 262 replaced by a glutamate residue (S262E-tau). The 
serine 262 is localized within the first tau repeat (R1) and has been 
shown to be phosphorylated in vivo in both physiological and path-
ological conditions (Seubert et al., 1995). Phosphorylation at this 
site reduced microtubule-stabilizing properties of tau through intra-
molecular modifications (Trinczek et al., 1995; Devred et al., 2002; 
Kiris et al., 2011). Here we showed that the phosphomimetic muta-
tion of tau on S262 induced a twofold decrease in tau interaction 
with EB1 as detected by pull-down assays (50.1% ± 15.8 of S262E-
tau bound to EB1 compared with tau, three independent experi-
ments, mean ± SD; Figure 5A). We next performed end-tracking 
experiments of GFP-EB1 with either tau or S262E-tau. We first 
showed that S262E-tau alone was still able to stabilize microtubules 
by lowering catastrophes and promoting rescues, albeit less effi-
ciently than tau (Figure 5D, compare third and fifth lines). In addi-
tion, with comparable tau:tubulin molar ratio used in the TIRF condi-
tions (1:160), we observed a similar proportion of tau and S262E-tau 
bound to microtubules, as shown by cosedimentation assays per-
formed on microtubules self-assembled with tau proteins (∼1 tau or 
FIGURE 3: Tau inhibitory effect on microtubule-tracking properties of 
EBs requires the C-terminal part of EBs. (A) Pull-down assays of tau 
with biotinylated-EB1 or biotinylated-EB1-NL-LZ. (B) Kymographs of 
microtubules assembled with 10 nM GFP-EB3 (left) or GFP-EB3-NL-LZ 
(right) in the absence (control) or presence of increasing 
concentrations of tau. Protein concentrations were decreased 
compared with conditions with GFP-EB1 and tau (Figure 1) to avoid 
GFP-EB3-NL-LZ binding to the microtubule lattice. Horizontal and 
vertical bars, 5 μm and 60 s, respectively. MT, microtubule. 
(C, D) Fluorescence intensity of GFP-EB3 (C) and GFP-EB3-NL-LZ 
(D) comets in the absence or presence of increasing concentrations of 
tau. ***p < 0.001; ****p < 0.0001; ns, nonsignificant; nonparametric 
Kruskal–Wallis ANOVA followed by post hoc Dunn’s comparison 
(42, 37, and 48 microtubules for EB3, EB3 + 10 nM tau, and 
EB3 + 40 nM tau, respectively; 22, 40, and 30 microtubules for 
EB3-NL-LZ, EB3-NL-LZ + 10 nM tau, and EB3-NL-LZ + 40 nM tau, 
respectively). The p values were calculated in comparison to the 
conditions without tau. All error bars represent SD. a.u., arbitrary units.
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Growth rate  
(μm/min)
Shortening rate 
(μm/min)
Catastrophe frequency 
(events/min)
Rescue frequency 
(events/min)
Control 1.47 ± 0.28 28.53 ± 12.6 0.127 ± 0.019 0
n = 62 n = 44 n = 44
GFP-EB3 (10 nM) 1.94 ± 0.35 28.17 ± 8.98 0.440 ± 0.030 0
n = 162 n = 136 n = 206
tau (10 nM) 1.43 ± 0.63 20.28 ± 12.96 0.014 ± 0.005 3.44 ± 1.3
n = 35 n = 7 n = 7 n = 7
tau (40 nM) 1.83 ± 0.20 37.41 0.001 10.01
n = 33 n = 1 n = 1 n = 1
GFP-EB3 + 10 nM tau 1.49 ± 0.34 26.90 ± 8.88 0.024 ± 0.006 2.57 ± 0.74
n = 48 n = 13 n = 15 n = 12
GFP-EB3 + 40 nM tau 1.83 ± 0.41 40.42 ± 14.64 0.004 ± 0.002 8.58 ± 6.06
n = 51 n = 2 n = 2 n = 2
GFP-EB3-NL-LZ (10 nM) 2.12 ± 0.46 25.99 ± 6.30 0.450 ± 0.034 0
n = 285 n = 177 n = 168
GFP-EB3-NL-LZ + 10 nM tau 2.29 ± 0.77 15.21 ± 5.90 0.315 ± 0.032 3.13 ± 0.32
n = 105 n = 92 n = 92 n = 92
GFP-EB3-NL-LZ + 40 nM tau 1.83 ± 0.52 20.48 ± 6.16 0.056 ± 0.010 2.07 ± 0.37
n = 55 n = 31 n = 31 n = 30
Dynamic parameters were measured for microtubules assembled with tubulin (12 μM) in the absence or presence of the indicated proteins. The total times of mea-
surements (growing and shrinkage phases) were 362.10, 497.24, 479.61, 513.44, 626.50, 457.13, 403.48, 321.11, and 565.12 min for tubulin alone, 10 nM GFP-EB3, 
10 nM tau, 40 nM tau, 10 nM GFP-EB3 + 10 nM tau, 10 nM GFP-EB3 + 40 nM tau, 10 nM GFP-EB3-NL-LZ, 10 nM GFP-EB3-NL-LZ + 10 nM tau, and 10 nM GFP-
EB3-NL-LZ + 40 nM tau, respectively. n, number of events measured for each condition. Values represent mean ± SD.
TABLE 2: Effects of EB3, EB3-NL-LZ, and tau on microtubule dynamics.
FIGURE 4: EB1 interacts with tau 
microtubule-binding sites. (A) Schematic 
representation of full-length tau and the 
constructs used in this study. The N-terminal 
extremity and the proline-rich P1 region 
constitute the projection domain of tau. The 
microtubule-binding domain includes the 
second proline-rich P2 region, the tandem 
repeats (R1–R4). and the pseudorepeat 
motif (R′). (B) Pull-down assays of the 
indicated tau proteins with biotinylated-EB1. 
(C) Kymographs of individual microtubules 
growing with 75 nM GFP-EB1 in the absence 
(control) or presence of 75 nM indicated tau 
protein. MT, microtubule. (D) Fluorescence 
intensity of EB1 comets in the absence or in 
the presence of the indicated tau proteins. 
****p < 0.0001; ns, nonsignificant; 
nonparametric Kruskal–Wallis ANOVA 
followed by post hoc Dunn’s comparison (32, 
27, 42, and 35 microtubules for EB1, EB1 + 
tau, EB1 + 0R-tau, and EB1 + R1R′-tau, 
respectively) and Mann–Whitney U test (30 
and 39 microtubules for EB1 and EB1 + 
P2R′-tau, respectively). The p values were 
calculated in comparison to the condition 
without tau. All error bars represent SD. a.u., 
arbitrary units.
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We next evaluated the effect of tau 
pseudophosphorylation on EB1 localization 
in fibroblasts expressing either tau or S262E-
tau (Figure 6). In agreement with previous 
reports (Seubert et al., 1995; Alonso et al., 
2010), S262E-tau was still able to bind to the 
microtubule lattice (Figure 6A, bottom). 
However, compared with the strong reduc-
tion of endogenous EB1 at microtubule 
ends in tau-transfected cells, S262E-tau ex-
pression did not induce any reduction of 
EB1 comets (Figure 6, A and B). Namely, the 
density (Figure 6C) and mean intensity 
(Figure 6D) of comets in S262E-tau trans-
fected cells were similar to those in non-
transfected cells. Furthermore, the average 
comet lengths were equivalent in S262E-
tau-transfected cells (2.58 μm ± 0.04, 132 
comets) and nontransfected cells (2.55 μm ± 
0.03, 247 comets). Overall these data show 
that S262E-tau interacts less efficiently with 
EBs than tau and has little effect on EB com-
ets at microtubule ends.
DISCUSSION
Structural MAPs primarily bind to and stabi-
lize the microtubule lattice (Amos and 
Schlieper, 2005), whereas EB proteins pref-
erentially accumulate at microtubule grow-
ing ends, where they modulate microtubule 
dynamics and microtubule interaction with 
cellular targets (Akhmanova and Steinmetz, 
2010). Recent studies reported a role for 
structural MAPs in the regulation of EB lo-
calization in cells (Kapitein et al., 2011; 
Tortosa et al., 2013; Sayas et al., 2015; Velot 
et al., 2015); however, the underlying mech-
anisms remain poorly understood. Here we 
show that tau inhibits the microtubule end–
tracking properties of EBs and that this inhi-
bition is regulated by tau phosphorylation. 
The interplay between EBs and tau results in 
large changes in microtubule dynamics. In 
particular, blocking the function of EBs in 
the presence of equimolar concentration of 
tau induces stably growing microtubules. By 
contrast, restoring EB end-tracking proper-
ties at substoichiometric amounts of tau (or 
in the presence of tau phosphomutant) 
leads to dynamic polymers alternating be-
tween catastrophes (EB-destabilizing activ-
ity) and rescues (tau-stabilizing activity).
From our results, we propose that the 
formation of a soluble complex between tau 
and EBs negatively regulates EB tracking at microtubule ends 
(Figure 7). First, tau and EBs directly interact via the C-terminal re-
gion of EBs and the microtubule-binding sites of tau (Figures 3 and 
4). Second, disruption of this complex by deletion of EB C-terminus 
(Figure 3) or phosphorylation of tau (Figure 5) causes the concomi-
tant binding of tau and EBs to microtubules. Third, tau does not re-
cruit EBs along microtubules (except in some cells expressing a high 
amount of tau; see later discussion), suggesting that EB-bound tau 
S262E-tau molecule per 100 dimers of polymerized tubulin; Supple-
mental Figure S5). In the presence of both S262E-tau and GFP-EB1, 
we still observed GFP-EB1 comets at microtubule ends with a fluo-
rescence intensity of ∼71 a.u. compared with 100 a.u. for GFP-EB1 
alone (Figure 5, B and C, right). Accordingly, microtubules under-
went catastrophes and rescues due to the opposing microtubule-
regulating activities of GFP-EB1 and S262E-tau (Figure 5D, sixth 
line).
FIGURE 5: S262E-tau interacts weakly with EB1 and does not inhibit EB1 tracking at 
microtubule ends. (A) Pull-down assays of tau and S262E-tau with biotinylated-EB1. One 
representative experiment. Quantifications indicate a decrease of 50.1% ± 15.8 of S262E-tau 
bound to EB1 compared with tau (three independent experiments, mean ± SD). 
(B) Quantification of fluorescence intensity of EB1 comets in the presence of tau or S262E-tau. 
*p < 0.05, ****p < 0.0001, nonparametric Kruskal–Wallis ANOVA followed by post hoc Dunn’s 
comparison (37, 25, and 26 microtubules for EB1, EB1 + tau, and EB1 + S262E-tau, respectively). 
The p values were calculated in comparison to the condition without tau. Error bars represent 
SD. a.u., arbitrary units. (C) Kymographs of microtubules assembled with 75 nM GFP-EB1 in the 
absence (control) or presence of 75 nM of tau (+ tau) or S262E-tau (+ S262E-tau). Horizontal and 
vertical bars, 5 μm and 60 s, respectively. MT, microtubule. (D) Microtubule dynamics for tubulin 
alone (control) or in the presence of EB1, tau, S262E-tau, EB1 + tau, or EB1 + S262E-tau. The 
total times of measurements were 233.14, 444.28, 487.57, 567.19, 821.12, and 1014.26 min for 
tubulin alone, EB1, tau, EB1 + tau, S262E-tau, and EB1+S262E-tau, respectively. n, number of 
events measured for each condition. Values represent the mean ± SD.
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tities of tau versus tubulin are able to sup-
press microtubule dynamics (Tables 1 and 2; 
Panda et al., 1995, 2003). We therefore 
speculate that, in these conditions, the frac-
tion of tau molecules not bound to EBs is 
sufficient to induce microtubule stabiliza-
tion. Of note, the very fast turnover of tau 
onto microtubules that has been recently 
described in neurons is compatible with tau 
interaction with multiple partners (Janning 
et al., 2014), which could also explain its ca-
pacities to both stabilize microtubules and 
bind EB proteins.
Alternatively, the association of tau with 
microtubules might indirectly influence EB 
localization by competing with the microtu-
bule sites recognized by EBs and/or affect-
ing the whole polymer structure. Accord-
ingly, tau has been proposed to induce 
lattice structural modifications even at low 
tau:tubulin molar ratios, in the range of 
those used in the present study (Choi et al., 
2009). However, these hypotheses fail to ex-
plain the localization of EB3-NL-LZ at micro-
tubule ends in the presence of tau (Figure 
3), as well as the ability of EB1 to end-track 
microtubules copolymerized with S262E-
tau, which still binds and stabilizes microtu-
bules (Figures 5 and 6).
The inhibition of EB tracking at microtu-
bule ends by tau in reconstitution assays is 
reminiscent of EB comet reduction in cells. 
Indeed, a decrease in EB localization to mi-
crotubule plus ends is observed in fibro-
blasts regardless of tau expression level 
(Figures 2 and 6) and also in neurons upon 
high tau expression (Sayas et al., 2015). In-
triguingly, high tau expression in both cell 
types (Supplemental Figure S1; Sayas et al., 
2015) leads to the relocation of EBs along 
tau-induced microtubule bundles, a phe-
nomenon that we did not observe in puri-
fied cell-free systems. The presence of many 
MAPs and kinases in cells, as well as various 
expression levels of tau during neuronal developmental stages and/
or between subcellular compartments, may account for these differ-
ences. Furthermore, high tau concentrations have been proposed 
to trigger the formation of tau oligomers on the microtubule surface 
(Ackmann et al., 2000); such tau oligomers with multiple microtu-
bule- and EB-binding sites could induce the recruitment of EBs 
along microtubule bundles in cells expressing high amounts of tau, 
as recently proposed in neurons (Sayas et al., 2015).
Of importance, the phosphomimetic mutation of tau within its 
microtubule-binding repeats strongly reduces tau/EB1 interaction. 
Furthermore, the S262E-tau mutant has only little effect on EB1 
comets in both reconstituting assays and fibroblasts (Figures 5 
and 6). In the presence of S262E-tau, EB1 can still bind to microtu-
bule ends and exert its intrinsic catastrophe-promoting activity. 
Consequently, microtubules undergo both catastrophe and rescue 
events as a result of the combined activities of EB1 and S262E-tau 
(Figure 7C). Taken together, these data strongly suggest that the 
inhibitory effect of tau on EB localization to microtubule ends is 
remains soluble (Figures 1E and 2). Moreover, the interaction be-
tween tau and EBs likely induces EB conformational changes, as tau 
binding to the C-terminal domain of EB1 results in fluorescence 
modifications of tryptophan residues that are located in the EB1 N-
terminal region (Supplemental Figure S3). Tau could thus sequester 
EBs and/or affect EB conformation upon binding, thereby hamper-
ing +TIP localization to microtubule ends (Figure 7). The formation 
of such a complex might also affect tau properties, since EBs recog-
nize the microtubule-binding sites of tau and should compete with 
tau/microtubule interaction. Indeed, the inhibitory activity of tau on 
catastrophes is impaired at substoichiometric amounts of tau com-
pared with EB1, in agreement with the partial release of microtu-
bule-bound tau by an excess of free EB1 (Figure 1 and Supplemen-
tal Figure S1). Strikingly, in the presence of equimolar concentrations 
of tau and EBs, tau still stabilizes microtubules (low catastrophe fre-
quency associated with rescues), although it inhibits EB localization 
at MT ends (Figures 1, 3, and 5). We explain this behavior by the 
strong microtubule-stabilizing properties of tau: even very low quan-
FIGURE 6: S262E-tau does not inhibit endogenous EB1 localization at microtubule ends. 
(A) Mouse embryonic fibroblasts were transfected with either pcDNA-tau (tau, top) or pcDNA-
S262E-tau (S262E-tau, bottom) and stained for tau (gray), EB1 (red), and tubulin (MT, green). 
Right, merged images with EB1 and tubulin staining. Images include nontransfected and 
transfected cells in the same field. Bar, 10 μm. MT, microtubule. (B) Higher magnifications of cells 
transfected with pcDNA-tau (+tau) and pcDNA-S262E-tau (+S262E-tau). Arrowheads point to 
EB1 comets. Bar, 10 μm. (C) EB1 comet density normalized to the microtubule network surface 
(comet number/100 μm2 of microtubule network) in lamellipodia of nontransfected cells (−tau) 
and cells transfected with tau (+tau) or S262E-tau (+S262E-tau). The histogram shows the mean 
± SEM. **p < 0.01; ns, nonsignificant; nonparametric Kruskal–Wallis ANOVA followed by post 
hoc Dunn’s comparison (74, 46, and 52 regions of interest for –tau, +tau, and +S262E-tau 
conditions, respectively). The p values were calculated in comparison to the condition without 
tau. (D) The fluorescence intensity of comets was quantified in nontransfected (−tau) and 
transfected cells (+tau and +S262E-tau) and plotted against distance from microtubule plus 
ends. Nonlinear regression curves fitting the mean fluorescence intensities ± SEM (247, 177, 
and 132 comets for –tau, +tau, and +S262E-tau cells, respectively). a.u., arbitrary units.
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(residues 1–189) and EB3 (residues 1–200) 
fused to the coiled-coil domain of GCN4 
(Buey et al., 2011). The EB1-K100E/Q102E 
mutant (named EB1-KQ/EE in the text) was 
generated by PCR using the QuikChange II 
XL site directed-mutagenesis kit. The GFP-
EB1 mutant lacking the last 20 amino acid 
residues (GFP-EB1-Δ-tail) was generated by 
a PCR-based strategy.
For pEGFP-tau, pcDNA-tau, and pcDNA-
S262E-tau constructs, tau (1N4R isoform) or 
S262E-tau were PCR-amplified from the pD-
EST constructs described and inserted into 
the pEGFP-C1 or pcDNA3.1 (+) plasmids us-
ing the In-Fusion HD Cloning kit (Clontech, 
Takara, Mountain View, CA).
Antibodies
For immunofluorescence, primary antibod-
ies (Abs) were a mouse monoclonal Ab 
against the C-terminal part of EB1 (610534; 
BD Biosciences, San Jose, CA), a rabbit poly-
clonal Ab against human tau (A0024; Dako, 
Glostrup, Denmark), a rabbit polyclonal Ab 
against enhanced GFP (EGFP: AB3080, Mil-
lipore, Temecula, CA), and a rat monoclonal 
Ab against tyrosinated tubulin (clone YL1/2; 
Wehland and Willingham, 1983). Secondary 
antibodies were coupled to Alexa 488, Alexa 
647 or Cyanine3 (Jackson Immuno-Research Laboratories, West 
Grove, PA).
Protein purification
Recombinant EB proteins were purified as described (Buey et al., 
2011) and stored in K-BRB80 buffer (80 mM 1,4-piperazinediethane-
sulfonic acid, 1 mM ethylene glycol tetraacetic acid, 1 mM MgCl2, 
50 mM KCl, pH 6.8) and 20 mM Tris-HCl and 150 mM NaCl (pH 7.0), 
respectively. Histidine-tag recombinant tau proteins were purified 
using Talon metal affinity resin (Clontech) and further processed by 
size exclusion chromatography in BRB80 buffer. Tubulin was purified 
from bovine brain and fluorescently labeled with ATTO-565 (ATTO-
Tech, Siegen, Germany) as previously described (Hyman et al., 
1991). Protein concentrations refer to monomers for tau and EBs 
and to dimers for tubulin.
Pull-down assays
EB1 and EB1-NL-LZ proteins were biotinylated using the EZ-Link 
NHS-Chromogenic Biotinylation Kit (ThermoFisher Scientific, 
Waltham, MA). A 5-μg amount of biotinylated EB1 was incubated 
in 300 μl of PD-buffer (40 mM Tris-HCl, 50 mM NaCl, 0.05% Triton 
X-100, pH 7.0) with 5, 3.2, 1.9, and 2.1 μg of tau/S262E-tau, 
0R-tau, R1R′-tau, and P2R′-tau, respectively (quantities of tau pro-
teins were adjusted to obtain the same final molar concentra-
tions). Samples were incubated for 15 min at 4°C before addition 
of streptavidin magnetic beads (ThermoFisher Scientific) and 
60 min of incubation at 4°C. Streptavidin beads were washed in 
PD-buffer and resuspended in denaturating Laemmli sample buf-
fer. Tau proteins recovered with beads were detected by Western 
blot using a polyclonal anti-tau primary antibody (dilution 
1:10,000; Dako) and a horseradish peroxidase–conjugated anti-
rabbit secondary antibody (1:2000; ThermoFisher Scientific), fol-
lowed by enhanced chemiluminescence revelation. EB1 bound to 
regulated by tau phosphorylation and open new perspectives on 
molecular dysfunctions possibly involved in tauopathies, such as 
Alzheimer’s disease. Indeed, tau abnormal phosphorylation in 
these pathologies may have a direct effect on EB functions in 
neurons.
In conclusion, our work shows that tau directly antagonizes EB 
proteins through a phosphorylation-dependent mechanism, provid-
ing a new model for the regulation of EB end-tracking properties. 
Such a mechanism may represent an important way of regulation for 
microtubule dynamics and organization in neurons, where both 
types of protein are present and the importance of microtubules for 
the cell architecture is prominent.
MATERIALS AND METHODS
DNA constructs
We used the human tau isoform with one N-terminal insertion (N) 
and four microtubule-binding repeat (R) motifs (1N4R-tau, 412 
amino acids; National Center for Biotechnology Information refer-
ence sequence NP_001116539.1) subcloned in the pDEST17 vector 
(kindly provided by N. Sergeant, Centre de Recherche Jean-Pierre 
Aubert, Lille, France). Deletion tau constructs were generated by a 
PCR-based strategy: 0R-tau, R1R′-tau, and P2R′-tau lack the Q244–
K369 domain; the M1–Y168 and G372–L412 domains; and the M1–
L243 and G372–L412 domains, respectively (amino acid numbers 
are given according to the longest 2N4R-tau isoform). Phosphomi-
metic tau mutant was generated by PCR using the QuikChange II XL 
site directed-mutagenesis kit (Agilent Technologies, Santa Clara, 
CA) to exchange the serine 262 by a glutamic acid residue (the S262 
site refers to the amino acid sequence of the 2N4R-tau isoform). 
Mouse EB1 and human EB1-NL-LZ, GFP-EB1, GFP-EB3, and 
GFP-EB3-NL-LZ plasmids were kindly provided by M. Steinmetz 
(Paul Scherrer Institut, Villigen, Switzerland). EB1-NL-LZ and 
GFP-EB3-NL-LZ correspond to the N-terminal domains of EB1 
FIGURE 7: Model for the inhibitory activity of tau on EB tracking at microtubule ends. (A) In the 
absence of tau, EB1 binds to microtubule ends and exerts its intrinsic catastrophe-promoting 
activity. (B) The microtubule-binding domain (MTBD) of tau directly interacts with the C-terminal 
part of EB1. This interaction would hamper EB1 localization to microtubule ends through EB1 
sequestration (i) and/or EB1 conformational changes (stars; ii). In these conditions, the 
catastrophe frequency decreases concomitantly with the apparition of rescues. (C) The 
phosphomimetic mutation S262E within tau MTBD impairs EB1/tau interaction and prevents 
tau-mediated inhibition of EB1 comets at microtubule ends. Microtubules are dynamic and 
undergo both catastrophes and rescues due to the opposing activities of EB1 and S262E-tau.
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setup and laser intensity. Microtubule dynamic parameters were 
determined on kymographs using ImageJ software. Growing and 
shortening rates of microtubules were calculated from the slopes 
of individual growth or shrinkage phases. The catastrophe and res-
cue frequencies were determined by dividing the total number of 
events by the time spent in growing and shrinking phases, respec-
tively. For these two parameters, the SD corresponds to the rescue 
(or catastrophe) frequency divided by √n, where n is the number of 
the total observed events, assuming a Poisson distribution (Walker 
et al., 1988).
Cell culture, transfection, immunofluorescence, 
and image quantification
Mouse embryonic fibroblasts were prepared from embryonic day 
14.5 embryos following standard procedures and cultured in DMEM 
and 1 g/l glucose with 10% fetal bovine serum. Transient transfec-
tions were carried out with 3 μg of plasmid DNA per 35-mm dish 
using Lipofectamine LTX reagent (ThermoFisher Scientific) and ac-
cording to the manufacturer’s protocol. After 24 h of transfection, 
cells were fixed by a 10-min incubation in methanol at −20°C. 
Immunofluorescence was performed using standard procedures. 
Fluorescence images were acquired with a Zeiss LSM 710 confocal 
microscope using a 63× oil-immersion objective (NA 1.4) and ZEN 
2010 software (Carl Zeiss MicroImaging, Oberkochen, Germany). 
Acquisition settings were identical between all images for one set of 
experiments to allow quantifications and comparisons.
Quantification of EB1 comet densities was performed on regions 
of interest drawn around cell lamellipodia using a homemade macro 
on ImageJ software (Schneider et al., 2012). First, in order to calcu-
late the microtubule network surface, a binary image was produced 
by applying a bandpass filter and automatic thresholding to the mi-
crotubule channel. Second, to detect comets, the same procedure 
was applied to the EB1 channel. Comets located onto microtubules 
were recovered by multiplying the two binary images. The comet 
density was obtained by dividing the number of comets by the mi-
crotubule network surface.
Length and fluorescence intensity of comets were quantified 
by drawing a line scan over a comet at microtubule end. At least 
20 comets per cell were quantified, and the mean intensity was 
calculated by subtracting the background for each cell. Comet 
fluorescence intensities for at least five cells per condition were 
averaged and plotted against the distance from the microtubule 
plus end.
Statistics
All statistical analyses were done using Prism 6 (GraphPad Software, 
La Jolla, CA).
the beads was visualized on Coomassie-stained gels. Differences 
in tau and S262E-tau interaction with EB1 were quantified on 
immunoblots using ImageJ software (Schneider et al., 2012). For 
pull-down experiments comparing tau interaction with EB1-NL-LZ 
and EB1, EB proteins associated with magnetic beads were de-
tected on Western blot using an anti-biotin antibody (1:2000) and 
anti-mouse EB1 (1:2000).
Microtubules/tau cosedimentation assays
To compare the proportion of tau and S262E-tau bound to mi-
crotubules, microtubules were self-assembled in the presence of 
tau or S262E-tau proteins in K-BRB80 buffer supplemented with 
1 mM GTP at 32°C and at a tau:tubulin molar ratio of 1:160 
(40 μM tubulin dimers with 0.25 μM tau or S262E-tau). After 
30 min of incubation, microtubules were centrifuged for 30 min 
at 230,000 × g and analyzed by SDS–PAGE. The amounts of tau 
bound to microtubules and of total polymerized tubulin were de-
termined on immunoblots and Coomassie-stained gels, respec-
tively. In the absence of microtubules, no tau was detected in the 
pellet.
TIRF microscopy, image analysis, and microtubule dynamics
Perfusion chambers were functionalized with silane-PEG-biotin 
(Laysanbio, Arab, AL) coverslips and silane-PEG (Creative PEG-
work, Chapel Hill, NC) glass slides as described (Elie et al., 2015). 
The flow cell was perfused with NeutrAvidin (25 μg/ml in 1% bo-
vine serum albumin [BSA]; ThermoFisher Scientific), PLL-g-PEG 
(2 kDa, 0.1 mg/ml in 10 mM 4-(2-hydroxyethyl)-1-piperazineethane-
sulfonic acid, pH 7.4; Jenkem, Plano, TX), 1% BSA in BRB80, and 
GMPCPP-stabilized, ATTO-565–labeled microtubule seeds. Micro-
tubules assembly was initiated with 12 μM tubulin (containing 30% 
ATTO 565–labeled tubulin) in the presence of various combina-
tions of GFP-EBs and tau proteins in TIRF assay buffer (4 mM 
dithiothreitol, 1% BSA, 50 mM KCl, 1 mg/ml glucose, 70 μg/ml 
catalase, 580 μg/ml glucose oxidase, and 0.1% methylcellulose 
[4000 cP; Sigma-Aldrich, St. Louis, MO] in BRB80). For experi-
ments with GFP-EB1, final concentrations of GFP-EB1 (monomers) 
and tau proteins (tau, R1R′-tau, and P2R′-tau) were fixed to 75 nM. 
The concentration of 0R-tau was increased to 500 nM since the 
deletion of the repeats drastically inhibits its microtubule-stabiliz-
ing properties (Trinczek et al., 1995). For experiments with EB3-
GFP and GFP-EB3-NL-LZ, we decreased the GFP-EB concentra-
tion (monomers) to 10 nM to avoid extensive microtubule lattice 
binding of GFP-EB3-NL-LZ (Buey et al., 2011). Tau concentrations 
were fixed to 10 and 40 nM. Dual-color time-lapse imaging was 
performed on an inverted Eclipse Ti (Nikon, Melville, NY) micro-
scope with an Apochromat 60×/1.49 numerical aperture (NA) oil 
immersion objective (Nikon) equipped with an ilas2 TIRF system 
(Roper Scientific, Evry, France) and a cooled charged-coupled de-
vice camera (EMCCD Evolve 512; Photometrics, Tucson, AZ) and 
was controlled by the MetaMorph 7.7.5 software (Molecular De-
vices, Sunnyvale, CA). For excitation, we used 491- and 561-nm 
lasers and performed time-lapse imaging at 1 frame per 2 s with an 
80-ms exposure time.
All image analysis was done with ImageJ software and a home-
made KymoTool. Comet fluorescence intensities were measured 
on the frames of the first 90 s of time-lapse movies using kymo-
graphs with background subtraction (Maurer et al., 2011). The 
maximum fluorescence intensity at microtubule growing ends was 
measured in the green channel with a 5-pixel-wide line. Compari-
sons of fluorescence intensities with and without tau proteins were 
calculated from experiments performed with the same acquisition 
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